ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EKF Ekf Diagnostics Holdings Plc

28.60
1.10 (4.00%)
Last Updated: 08:10:38
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.10 4.00% 28.60 27.10 28.70 28.60 28.60 28.60 75,068 08:10:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 52.61M 2.35M 0.0052 55.00 130.11M

EKF Diagnostics Holdings PLC Grant of Options (5615J)

12/09/2016 10:24am

UK Regulatory


Ekf Diagnostics (LSE:EKF)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ekf Diagnostics Charts.

TIDMEKF

RNS Number : 5615J

EKF Diagnostics Holdings PLC

12 September 2016

12 September 2016

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Grant of Options

EKF Diagnostics Holdings plc (AIM: EKF) announces that, on 12 September 2016, the Company granted options ("Options") over a total of 6,600,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's Unapproved Share Option Plan. Of these Options, 5,800,000 were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company, with 800,000 granted to one other employee.

All Options will vest on 12 September 2019 subject to achievement by the individual recipient of specific performance-related criteria and continuous employment, except that they will vest automatically upon the sale of the Company. The Options are exercisable at 15 pence per Ordinary Share, with an expiry date for exercise of 12 September 2026.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
  1   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  -------------------------------------------------------------- 
 a)   Names                     Steven Wray - Head of Sales EMEA 
                                 Gilbert Mejia - Head of Sales 
                                 Americas 
                                 Martyn Lewis - Head of Marketing 
                                 Peter Coyne - Head of Operations 
                                 Ed Hitchler - General Manager, 
                                 EKF USA 
                                 Steffan Borlich - General Manager, 
                                 EKF Germany 
                                 Salim Hamir - Company Secretary 
                                 and Head of Corporate Affairs 
                                 Colin Anderson - Deputy Finance 
                                 Director 
---  ------------------------  ------------------------------------ 
 2    Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status           See 1(a) above for positions - 
                                 all classified as PDMRs of EKF 
---  ------------------------  ------------------------------------ 
 b)   Initial notification      Initial Notification 
       /Amendment 
---  ------------------------  ------------------------------------ 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  -------------------------------------------------------------- 
 a)   Name                      EKF Diagnostics Holdings plc 
---  ------------------------  ------------------------------------ 
 b)   LEI 
---  ------------------------  ------------------------------------ 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and 
       (iv) each place where transactions have been 
       conducted 
---  -------------------------------------------------------------- 
 a)   Description of            In each case, the grant of Options 
       the financial             on 12 September 2016 over Ordinary 
       instrument, type          Shares 
       of instrument 
---  ------------------------  ------------------------------------ 
 b)   Identification            GB0031509804 
       code 
---  ------------------------  ------------------------------------ 
 c)   Nature of the             Grant of Options over Ordinary 
       transaction               Shares pursuant to the Company's 
                                 Unapproved Share Option plan 
---  ------------------------  ------------------------------------ 
 d)   Price(s) and              Price - n/a 
       volume(s)                 Volume(s) 
                                 Steven Wray - 800,000 Options 
                                 Gilbert Mejia - 800,000 Options 
                                 Martyn Lewis - 800,000 Options 
                                 Peter Coyne - 800,000 Options 
                                 Ed Hitchler - 800,000 Options 
                                 Steffan Borlich - 800,000 Options 
                                 Salim Hamir -500,000 Options 
                                 Colin Anderson - 500,000 Options 
---  ------------------------  ------------------------------------ 
 d)   Aggregated information     N/a 
       - Aggregated 
       volume 
       - Price 
---  ------------------------  ------------------------------------ 
 e)   Date of the transaction   12 September 2016 
---  ------------------------  ------------------------------------ 
 f)   Place of the              Outside a trading venue 
       transaction 
---  ------------------------  ------------------------------------ 
 

Name of authorised official of issuer responsible for making notification.

Salim Hamir

Company Secretary to EKF Diagnostics Holdings plc

For further information:

 
EKF Diagnostics Holdings                          Tel: 029 2071 0570 
plc 
Julian Baines, CEO 
Richard Evans, FD & 
 COO 
 
Panmure Gordon (UK)                               Tel: 020 7886 2500 
 Limited 
Peter Steel 
Freddy Crossley 
 
Walbrook PR Limited         Tel: 020 7933 8780 or ekf@walbrookpr.com 
Paul McManus                                      Mob: 07980 541 893 
Lianne Cawthorne                                  Mob: 07584 391 303 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGCGDCGDBBGLD

(END) Dow Jones Newswires

September 12, 2016 05:24 ET (09:24 GMT)

1 Year Ekf Diagnostics Chart

1 Year Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart

Your Recent History

Delayed Upgrade Clock